Esperion Therapeutics’ Royalty Purchase Agreement with OMERS

Leila Ahmed
Tagged:

Gibson Dunn & Crutcher advised Esperion Therapeutics, Inc. on the deal.Esperion Therapeutics, Inc. (Nasdaq: ESPR) announced that it has entered into a Royalty Purchase Agreement (the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now